BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25733682)

  • 1. The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.
    Di Giorgio E; Gagliostro E; Clocchiatti A; Brancolini C
    Mol Cell Biol; 2015 May; 35(9):1633-47. PubMed ID: 25733682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition.
    Badodi S; Baruffaldi F; Ganassi M; Battini R; Molinari S
    Cell Cycle; 2015; 14(10):1517-28. PubMed ID: 25789873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
    Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
    Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
    Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
    Yeh KH; Kondo T; Zheng J; Tsvetkov LM; Blair J; Zhang H
    Biochem Biophys Res Commun; 2001 Mar; 281(4):884-90. PubMed ID: 11237742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEF2D overexpression contributes to the progression of osteosarcoma.
    Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
    Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MEF2-HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro.
    Clocchiatti A; Di Giorgio E; Viviani G; Streuli C; Sgorbissa A; Picco R; Cutano V; Brancolini C
    J Cell Sci; 2015 Nov; 128(21):3961-76. PubMed ID: 26403201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation.
    Al-Khalaf HH; Hendrayani SF; Aboussekhra A
    Mol Cancer Res; 2011 Mar; 9(3):311-9. PubMed ID: 21270107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAK4 is required for regulation of the cell-cycle regulatory protein p21, and for control of cell-cycle progression.
    Nekrasova T; Minden A
    J Cell Biochem; 2011 Jul; 112(7):1795-806. PubMed ID: 21381077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2.
    Rodier G; Makris C; Coulombe P; Scime A; Nakayama K; Nakayama KI; Meloche S
    J Cell Biol; 2005 Jan; 168(1):55-66. PubMed ID: 15631990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
    Afshari CA; Nichols MA; Xiong Y; Mudryj M
    Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ets transcription factor GABP is required for cell-cycle progression.
    Yang ZF; Mott S; Rosmarin AG
    Nat Cell Biol; 2007 Mar; 9(3):339-46. PubMed ID: 17277770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
    Liu S; Yamauchi H
    Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [E1A oncogene effect on the ability of p21(Waf1) to regulate G1/S arrest in E1A-expressing transformants following irradiation].
    Romanov VS; Brichkina AI; Pospelov VA; Pospelova TV
    Tsitologiia; 2005; 47(12):1063-70. PubMed ID: 16706194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.